Breaking systemic barriers to women’s participation in science
Who can apply?
The call underscores IDRC’s commitment to support a major research effort to:
Who can apply?
The call underscores IDRC’s commitment to support a major research effort to:
This call is open to:
Please note: the expectation of receiving a post-graduation work permit is not sufficient.
Other eligibility requirements
Please note: Successful award recipients cannot receive any other Canadian government scholarship, award, subsidy, bursary, or honorarium, or hold any federal government contract in support of a research/work project for the duration of the award. This includes any other IDRC award and any award managed by another institution but supported in whole or in part by IDRC, such as the Queen Elizabeth Advanced Scholars program.
Research award recipients will join IDRC for a one-year paid program to undertake research on the topic they have submitted. They will receive hands-on experience in research and program management and support, grant administration, and the creation, dissemination, and use of knowledge from an international perspective.
For payroll purposes, awardees are considered full-time employees of IDRC. Benefits include employer contributions to employment insurance, employer health tax, the Canada Pension Plan, and paid vacation leave. Some travel and research expenses are also supported, up to a maximum of CA$15,000.
The Ontario HIV Treatment Network’s (OHTN) HIV Endgame program seeks to support people and projects that have the potential to:
Our current funding opportunities are listed below. The Letter of Intent (LOI) application deadline is Friday, July 12, 2019.
1. Endgame Leader Awards: Salary support for leaders at different stages of their careers who are interested in working with the OHTN to drive change.
2. Game Changer Awards: Project funding to generate game-changing knowledge, pilot and scale-up game-changing interventions.
3. Community-Based Project and Participatory Evaluation Awards: Project funding for community-based agencies and people living with HIV to undertake projects and evaluation that will have a meaningful impact on programs and services for those most affected by HIV.
To learn more about these awards, click: http://www.ohtn.on.ca/endgame-funding-program/
The CIHR Sex and Gender Science Chairs Initiative is expected to:
The purpose of this funding opportunity is to advance clinical research in women’s health and to build capacity in the next generation of women’s health clinician-researchers. The aim is for trainees, students or residents to be paired with and mentored by a women’s health clinician-specialist on a one-year research project with the goal of improving clinical care.
The research question(s) must:
The specific objectives of this funding opportunity are:
The Indigenous Gender and Wellness Development Grant funding opportunity is expected to:
The 2019 Early Career Investigator Awards in Circulatory and Respiratory Health are expected to:
The CIHR Dementia Research Strategy supports research on the latest preventive, diagnostic and treatment approaches to Alzheimer's disease and other neurodegenerative diseases causing dementia. It consists of an international and a national component, which together, allows the Government of Canada to support world-class research on dementia, contributing to the global pursuit of finding a cure or disease-modifying treatment for dementia by 2025.
The Canadian Consortium on Neurodegeneration in Aging (CCNA) is the Canadian component of the CIHR Dementia Research Strategy representing the Center of Excellence for Canada. CCNA is the premier research hub for all aspects of research involving neurodegenerative diseases that affect cognition in aging – including Alzheimer's disease.
The Network of Centres of Excellence in Neurodegeneration (CoEN) is an international initiative, which will connect Centers of Excellence (CoEs) with a critical mass of resources and expertise to drive a step-change in neurodegeneration research. As such, the Lead Canadian Principal Applicant for this funding opportunity must be a CCNA member. It is expected that teams will combine the research strengths across CoEs in at least two partner countries to provide a true value-added collaborative effort that will advance our approach to neurodegeneration research. Projects will address issues which would not readily be funded through the standard grant mechanisms of the CoEN partners, and it is expected that in addition to collaboration across CoEs, projects should also serve to provide a platform for future collaboration with industry.
This funding opportunity seeks to address the need for innovative research to underpin new approaches to therapeutic intervention. The call sets out to encourage “outside the box” thinking, to stimulate new and unconventional approaches and creative solutions to the challenges of neurodegeneration research by undertaking high-risk / high-payoff research.
For more information, please consult the Centres of Excellence in Neurodegeneration (CoEN) website.